Healthcare startup Abridge has raised $300 million Series E at a $5.3 billion valuation, led by Andreessen Horowitz, to enhance revenue cycles and connect clinicians with billing teams.
Healthcare startup Abridge has raised $300 million Series E at a $5.3 billion valuation, led by Andreessen Horowitz, to enhance revenue cycles and connect clinicians with billing teams.
06/24/25, 2:35 PM
Location
san franciscoMoney raised
$300 million
Industry
artificial intelligence
health care
Round Type
series e
Investors
Khosla Ventures, Andreessen Horowitz
Abridge, which leverages AI for medical documentation, has raised $300 million in a Series E round, boosting its valuation to $5.3 billion.. This funding round focuses on improving revenue cycles and clinician-billing team collaboration. The lead investor is Andreessen Horowitz, with Khosla Ventures participating. Abridge is also expanding its partnerships with over 150 U.S
Company Info
Location
san francisco, california, united states
Additional Info
Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. Our AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients.
Our enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time, with deep EMR integrations. Powered by Linked Evidence and our purpose-built, auditable AI, we are the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, we are setting the industry standards for the responsible deployment of AI across health systems.